Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1991; Volume 40,Issue 1
  • You have access
    Cloning and expression of an A1 adenosine receptor from rat brain.
    L C Mahan, L D McVittie, E M Smyk-Randall, H Nakata, F J Monsma, C R Gerfen and D R Sibley
    Molecular Pharmacology July 1991, 40 (1) 1-7;
  • You have access
    Three-dimensional models of neurotransmitter G-binding protein-coupled receptors.
    M F Hibert, S Trumpp-Kallmeyer, A Bruinvels and J Hoflack
    Molecular Pharmacology July 1991, 40 (1) 8-15;
  • You have access
    Novel receptor site involved in enhancement of stimulus-induced acetylcholine, dopamine, and serotonin release.
    S W Tam, D Rominger and V J Nickolson
    Molecular Pharmacology July 1991, 40 (1) 16-21;
  • You have access
    5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
    J F Evans, C Lévillé, J A Mancini, P Prasit, M Thérien, R Zamboni, J Y Gauthier, R Fortin, P Charleson and D E MacIntyre
    Molecular Pharmacology July 1991, 40 (1) 22-27;
  • You have access
    Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors.
    M Li, R P Yasuda, S J Wall, A Wellstein and B B Wolfe
    Molecular Pharmacology July 1991, 40 (1) 28-35;
  • You have access
    Purification, immunochemical characterization, and immunohistochemical localization of rat hepatic aryl sulfotransferase IV.
    M W Duffel, T P Binder, L Hosie, H A Baden, J A Sanders, S A Knapp and J Baron
    Molecular Pharmacology July 1991, 40 (1) 36-44;
  • You have access
    Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons.
    C F Zorumski, L L Thio and D B Clifford
    Molecular Pharmacology July 1991, 40 (1) 45-51;
  • You have access
    Pyridine effects on expression and molecular regulation of the cytochrome P450IA gene subfamily.
    S G Kim, S L Reddy, J C States and R F Novak
    Molecular Pharmacology July 1991, 40 (1) 52-57;
  • You have access
    Differences in the developmental expression of rabbit cytochromes P-450 2E1 and 2E2.
    H M Peng, T D Porter, X X Ding and M J Coon
    Molecular Pharmacology July 1991, 40 (1) 58-62;
  • You have access
    Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6.
    R F Tyndale, R Sunahara, T Inaba, W Kalow, F J Gonzalez and H B Niznik
    Molecular Pharmacology July 1991, 40 (1) 63-68;
  • You have access
    Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
    P K Srivastava, C H Yun, P H Beaune, C Ged and F P Guengerich
    Molecular Pharmacology July 1991, 40 (1) 69-79;
  • You have access
    Purification and properties of a rat liver phenobarbital-inducible 4-hydroxybiphenyl UDP-glucuronosyltransferase.
    P Styczynski, M Green, J Puig, B Coffman and T Tephly
    Molecular Pharmacology July 1991, 40 (1) 80-84;
  • You have access
    Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor.
    R A Jeffs, C L Cooper and T K Harden
    Molecular Pharmacology July 1991, 40 (1) 85-92;
  • You have access
    Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    V U Dissanayake, J Hughes and J C Hunter
    Molecular Pharmacology July 1991, 40 (1) 93-100;
  • You have access
    Muscarinic receptor-mediated prostacyclin and cGMP synthesis in cultured vascular cells.
    N Jaiswal, R K Jaiswal and K U Malik
    Molecular Pharmacology July 1991, 40 (1) 101-106;
  • You have access
    Noncompetitive inhibition of inositol monophosphatase by K-76 monocarboxylic acid.
    J A Pachter
    Molecular Pharmacology July 1991, 40 (1) 107-111;
  • You have access
    Tetrodotoxin-insensitive Na+ channel activator palytoxin inhibits tyrosine uptake into cultured bovine adrenal chromaffin cells.
    K Morita, K Teraoka, M Azuma, M Oka and S Hamano
    Molecular Pharmacology July 1991, 40 (1) 112-117;
  • You have access
    Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
    N R Hartman, G S Ahluwalia, D A Cooney, H Mitsuya, S Kageyama, A Fridland, S Broder and D G Johns
    Molecular Pharmacology July 1991, 40 (1) 118-124;
  • You have access
    Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol.
    V V Lauriault and P J O'Brien
    Molecular Pharmacology July 1991, 40 (1) 125-134;
  • You have access
    Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism.
    H K Kroemer, C Fischer, C O Meese and M Eichelbaum
    Molecular Pharmacology July 1991, 40 (1) 135-142;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 40, Issue 1
1 Jul 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics